Gilead Sciences Inc. ( GILD ) saw a big move last session, as the company's shares fell by over 7% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal session. This continues the recent downtrend for GILD, as the stock is now down almost 18% in the past one-month time frame.ALKERMES INC (ALKS): Free Stock Analysis ReportANI PHARMACEUT (ANIP): Free Stock Analysis ReportGILEAD SCIENCES (GILD): Free Stock Analysis ReportMYRIAD GENETICS (MYGN): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment Research
This biopharmaceutical company has seen a flat track record when it comes to current year estimate revisions over the past few weeks, and the consensus for earnings hasn't been in a trend either. This recent price action is discouraging, so make sure to keep a close watch on this firm in the near future, and especially on earnings estimates following the recent slump.
Gilead Sciences currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.0%.
Some better-ranked stocks in the same sector include Alexion Pharmaceuticals, Inc. ( ALXN ), Myriad Genetics Inc. ( MYGN ) and ANI Pharmaceuticals, Inc. ( ANIP ). ANI pharma and Myriad Genetics carry a Zacks Rank #1 (Strong Buy) while Alexion carries Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.Click to get this free report >>